Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 9:40 PM
Ignite Modification Date:
2025-12-24 @ 9:40 PM
NCT ID:
NCT05833932
Eligibility Criteria:
Inclusion Criteria:
* Acute ischemic stroke within 7 days of symptom onset.
* Age ≥ 18
* Patient who has received Suhexiang Pill treatment
* Patient or legally authorized representative has signed informed consent.
Exclusion Criteria:
* Be allergic to Suhexiang Pill
* Known to be pregnant or breastfeeding.
* With conditions that render outcomes or follow-up unlikely to be assessed.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT05833932
Study Brief:
Protocol Section:
NCT05833932